Japan Animal Referral Medical Center Co., Ltd. AI Stock Analysis
Want to see JP:6039 full AI Analyst Report?
Japan Animal Referral Medical Center Co., Ltd. (6039) AI Stock Analysis
Japan Animal Referral Medical Center Co., Ltd.
(TSE/TYO:6039)
Japan Animal Referral Medical Center scores moderately. The strongest support comes from fundamentals: rapid revenue growth, a projected 60% surge in FY2026 earnings, and an attractive 12.4x P/E with a 1.4% dividend yield. Offsetting this, the stock is in a pronounced downtrend, trading far below all key moving averages with negative MACD and weak momentum readings. Financially, the main risks are capital intensity and funding: free cash flow has been repeatedly negative and is projected at -¥953M in FY2026, while debt is set to climb to ¥5.16B, leaving execution on expansion investments as the key determinant of future performance.
Japan Animal Referral Medical Center Co., Ltd. (6039) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 11.63B
- Dividend Yield
- 1.28%
- Average Volume (3M)
- 60.07K
- Price to Earnings (P/E)
- 13.6
- Beta (1Y)
- 0.96
- Revenue Growth
- 13.65%
- EPS Growth
- 31.54%
- Country
- Japan
- Employees
- 328
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Personal Products & Services
Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model
Company Description
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized de...
Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview
Summary
Revenue has nearly doubled over five years (¥2.85B in FY2021 to ¥5.28B in FY2025) with a further 12.6% increase projected for FY2026 and a 60% jump in EBIT and net income, pointing to emerging operating leverage (Income Statement: 72). The balance sheet is adequate, with deleveraging from 1.56x to 0.84x debt-to-equity and steady equity accumulation, but debt is projected to rise sharply to ¥5.16B in FY2026 and ROE is only moderate at 12.6% (Balance Sheet: 62). Cash flow is the weakest link: operating cash flow is improving (¥1.37B in FY2025), but free cash flow is frequently negative and projected at -¥953M in FY2026 on heavy capex, leaving the company reliant on external financing (Cash Flow: 58).
Income Statement
72PositiveBalance Sheet
62PositiveCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.36B | 6.19B | 5.28B | 4.27B | 3.87B | 2.98B |
| Gross Profit | 2.65B | 2.51B | 1.81B | 1.43B | 1.41B | 1.07B |
| EBITDA | 1.81B | 1.74B | 1.29B | 961.39M | 996.73M | 680.27M |
| Net Income | 892.85M | 833.43M | 520.98M | 337.22M | 380.66M | 286.94M |
Balance Sheet | ||||||
| Total Assets | 11.24B | 11.31B | 8.75B | 8.77B | 8.58B | 7.11B |
| Cash, Cash Equivalents and Short-Term Investments | 1.25B | 1.59B | 1.11B | 1.34B | 1.92B | 1.07B |
| Total Debt | 5.16B | 5.16B | 3.48B | 3.86B | 3.98B | 3.92B |
| Total Liabilities | 6.28B | 6.43B | 4.61B | 4.96B | 4.87B | 4.60B |
| Stockholders Equity | 4.96B | 4.88B | 4.15B | 3.81B | 3.71B | 2.51B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -953.45M | 418.70M | -141.26M | 82.62M | -44.14M |
| Operating Cash Flow | 0 | 1.40B | 1.37B | 899.78M | 810.92M | 557.57M |
| Investing Cash Flow | 0 | -2.49B | -994.38M | -985.86M | -784.07M | -1.43B |
| Financing Cash Flow | 0 | 1.58B | -608.03M | -392.32M | 820.59M | 722.09M |
Japan Animal Referral Medical Center Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Negative. The current price of 939.00 is below the 20-day moving average (MA) of 955.95, below the 50-day MA of 985.44, and below the 200-day MA of 1130.97, indicating a bearish trend. The MACD of -19.53 indicates Negative momentum. The RSI at 45.15 is Neutral, neither overbought nor oversold. The STOCH value of 78.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6039.
Japan Animal Referral Medical Center Co., Ltd. Peers Comparison
Overall Rating
JP:603960Neutral
JP:962858Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6039 | Japan Animal Referral Medical Center Co., Ltd. | 939.00 | -187.53 | -16.65% | |
| JP:9628 | San Holdings, Inc. (Japan) | 1096.00 | -190.51 | -14.81% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
